A Study of BL-M05D1 in Patients With Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 19, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions

Locally Advanced or Metastatic Solid Tumors

Interventions

DRUG

BL-M05D1

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

RECRUITING

Beijing Cancer Hospital, Beijing

All Listed Sponsors

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY